Bitopertin
Top View
- Acamprosate Axis 1 Class Glutamate
- Psychosis, Agitation, and Antipsychotic Drugs
- AHRQ Healthcare Horizon Scanning System – Status Update Horizon
- NMDA Receptor Modulators: an Updated Patent Review (2013-2014) Katie L
- Long-Term Potentiation Prevents Ketamine-Induced Aberrant Neurophysiological Dynamics in the Hippocampus-Prefrontal Cortex Pathway in Vivo
- 2Februar 2014
- Membrane Transporter/Ion Channel
- Developing Drugs for Negative Symptoms of Schizophrenia
- Glycine Transporter Inhibitors and Act at a Binding Site of the NMDA Recep- Tor
- Glycine Exerts Dose-Dependent Biphasic Effects on Vascular Development of Zebrafish Embryos
- Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers
- A Possible Role for Sarcosine in the Management of Schizophrenia
- Glutamate in Schizophrenia
- (12) Patent Application Publication (10) Pub. No.: US 2014/0024644 A1 Hitchcock Et Al
- Bitopertin / Rg1678 / Ro4917838 F
- Evidence-Based Guidelines for the Pharmacological Treatment of Schizophrenia
- CNS SPECTRUMS CME Review Article Keeping up with the Clinical Advances: Schizophrenia
- (12) United States Patent (10) Patent No.: US 9,670.229 B2 Hitchcock Et Al